Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2007
11/15/2007WO2007128672A1 Substituted hexahydro-1,4-diazepin-5-ones and compositions stabilized therewith
11/15/2007WO2007128492A1 Novel pharmaceutical compositions
11/15/2007WO2007128454A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof
11/15/2007WO2007109080A3 Deuterated hepatitis c protease inhibitors
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007070600A3 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265326 Novel compounds
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265289 2-Aminopyrimidine Derivative
11/15/2007US20070265285 Quinazolinone derivatives and their use as CB agonists
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265262 viricides selecting from a group of compounds, carbamoyl-pyrrolidine-1-carboxylic acid benzyl ester derivatives; treating or preventing a viral infection; 2-(2',4'-Dimethoxy-biphenyl-4-ylcarbamoyl)-pyrrolidine-1-carboxylic acid benzyl ester
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265250 Imidazole compounds
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/15/2007US20070265240 Sequence Selective Pyrrole and Imidazole Polyamide Metallocomplexes
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070264600 Heterocyclic Colorants Based on Diazabenzoisoindoles
11/15/2007CA2654540A1 Histone deacetylase and tubulin deacetylase inhibitors
11/15/2007CA2651556A1 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
11/15/2007CA2651128A1 Benzimidazole modulators of vr1
11/15/2007CA2650553A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
11/15/2007CA2650114A1 Mglur5 modulators i
11/15/2007CA2649882A1 Novel pharmaceutical compositions
11/15/2007CA2647373A1 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/14/2007EP1853602A1 Chemical compounds
11/14/2007EP1853591A1 Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1853589A1 Process for preparing 2,3-disubstituted indoles
11/14/2007EP1853588A1 Chemical compounds
11/14/2007EP1853566A1 Cinnoline compounds and their use as liver x receptor modulators
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1409480B1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
11/14/2007CN101072771A Cgrp受体拮抗剂 Cgrp receptor antagonists
11/14/2007CN101072759A Triazole compounds that modulate hsp90 activity
11/14/2007CN101072758A 喹唑啉衍生物 Quinazoline derivatives
11/14/2007CN101072503A 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
11/14/2007CN101070319A Crystal state of anti-hepatitis-B-virus compound and its preparing method and use
11/14/2007CN101070318A Light-sensitive luminous europium complex and light-sensitive ligand molecular and their synthesizing method
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN100348596C Indole-3-carboxamides as glucokinase(GK) activators
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348196C Benzotriazepines as gastrin and cholecystokinin receptor ligands
11/13/2007USRE39921 Chemical compounds
11/13/2007US7294721 Alkylating the free amino group of (R)-2-(4-cyanophenylaminomethyl)-1-methyl-5-[1-amino-1-(pyrrolidinocarbonyl)-ethyl]-benzimidazole with an alkyl haloacetate, changing the cyano to an amidine, precipitating the p-toluenesulfonic acid salt, hydrolyzing the ester, and precipitating the HCl salt
11/13/2007US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294626 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007127763A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127704A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127635A2 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007WO2007127448A2 Salts of pyridazine compounds
11/08/2007WO2007126964A2 Kinase inhibitors
11/08/2007WO2007126871A1 P38 inhibitors and methods of use thereof
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125405A2 Substituted 2-amino-fused heterocyclic compounds
11/08/2007WO2007125061A1 Spirocompounds useful as modulators for dopamine d3 receptors
11/08/2007WO2007107470A3 Pyrazoles as 11-beta-hsd-1
11/08/2007WO2007103584A3 Polyamides for treating human papilloma virus
11/08/2007WO2007084450A3 Cannibinoid receptor modulators
11/08/2007WO2007084435A3 Methods for treating hepatitis c
11/08/2007US20070260063 Heterocyclical Anti-Aromatic Chromophore Architectures
11/08/2007US20070260040 Amino Acid Surrogates for Peptidic Constructs
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259942 Indolone derivatives like N2-[2-(5-Methyl-1H-3-indolyl)ethyl]-N4-(4-methylphenyl)-6-(1-piperidinyl)-2,4-pyrimidinediamine; galanin-type receptors; antidepressants; anxiolytic agents
11/08/2007US20070259937 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/08/2007US20070259932 Benzimidazole derivatives, their production and use
11/08/2007US20070259926 mGluR5 modulators III
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259924 such as 5-Chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, used to prevent or treat conditions characterized by undesired thrombosis and inhibiting the coagulation of blood samples
11/08/2007US20070259921 Polymorphic forms of esomeprazole sodium
11/08/2007US20070259916 mGluR5 modulators II
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259888 Novel Compounds
11/08/2007US20070259886 Dihydroxyphenyl isoindolylmethanones
11/08/2007US20070259885 Novel Crystal Form of(3-Cyano-1H-Indol-7-Yl)-[4-(4-Fluorophenethyl)Piperazin-1-Yl] Methanone, Hydrochloride
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259879 Piperazine and piperidine biaryl derivatives
11/08/2007US20070259877 Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders
11/08/2007US20070259870 Novel Pyridazinone Derivatives
11/08/2007US20070259867 2-Phenyl or benzylphthalimide-5-carboxamide N-substituted with a piperidinyl-, pyrrolidinyl-, morpholinyl-, or piperazinylalkyl group (1-{2-[(1,3-dioxo-2-phenyl-2,3-dihydro-1H-isoindol-5-carbonyl)-amino]-ethyl}-piperidinium chloride); treating epilepsy, hypertension and stenocardia
11/08/2007US20070259849 Azine-Carboxamides as Anti-Cancer Agents
11/08/2007US20070259848 N-({[1-(3,4-Dichloro-benzyl)-azetidin-3-ylmethyl]-carbamoyl}-methyl)-2-methoxy-benzamide; inflammatory or allergic condition such as an inflammatory or obstructive airways disease
11/08/2007DE102006012251A1 Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln Substituted 4-amino-quinazoline derivatives and to their use for the preparation of medicaments
11/08/2007CA2651072A1 Substituted 2-amino-fused heterocyclic compounds
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 626